Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Rubin

Showing results (621-630 of 717) with videos related to

Pageof 72
Sort By:
Cancer Research|June 19, 2001
Regulatory CD4(+)CD25(+) T cells in tumors from patients with early-stage non-small cell lung cancer and late-stage ovarian cancerE Y Woo, C S Chu, T J Goletz, et al.
Radiology|December 2, 1999
Necrotic tumor versus brain abscess: importance of amino acids detected at 1H MR spectroscopy--initial resultsS Grand, G Passaro, A Ziegler, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 2, 1999
Use of carrier cells to deliver a replication-selective herpes simplex virus-1 mutant for the intraperitoneal therapy of epithelial ovarian cancerG Coukos, A Makrigiannakis, E H Kang, et al.
Journal of the National Cancer Institute|June 13, 1998
Molecular evidence for multifocal papillary serous carcinoma of the peritoneum in patients with germline BRCA1 mutationsJ O Schorge, M G Muto, W R Welch, et al.
RNA (New York, N.Y.)|October 13, 2018
Apobec1 complementation factor (A1CF) and RBM47 interact in tissue-specific regulation of C to U RNA editing in mouse intestine and liverValerie Blanc, Yan Xie, Susan Kennedy, et al.
Cellular and Molecular Gastroenterology and Hepatology|August 11, 2024
A Novel CRISPR/Cas9-mediated Mouse Model of Colon CarcinogenesisHajime Kashima, Anthony Fischer, Daniel A Veronese-Paniagua, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 31, 2024
Quantum computation of stopping power for inertial fusion target designNicholas C Rubin, Dominic W Berry, Alina Kononov, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 21, 2007
Tumor residual after surgical cytoreduction in prediction of clinical outcome in stage IV epithelial ovarian cancer: a Gynecologic Oncology Group StudyWilliam E Winter, G Larry Maxwell, Chunqiao Tian, et al.
Gynecologic Oncology|January 11, 1991
Chemotherapy-induced neutropenia and fever in patients receiving cisplatin-based chemotherapy for ovarian malignancyJ P Curtin, W J Hoskins, S C Rubin, et al.
Gynecologic Oncology|September 28, 2011
A high response rate to liposomal doxorubicin is seen among women with BRCA mutations treated for recurrent epithelial ovarian cancerSarah F Adams, Evelyn B Marsh, Wafic Elmasri, et al.
Pageof 72

Showing results (621-630 of 717) with videos related to

Sort By:
Pageof 72
Cancer Research|June 19, 2001
Regulatory CD4(+)CD25(+) T cells in tumors from patients with early-stage non-small cell lung cancer and late-stage ovarian cancerE Y Woo, C S Chu, T J Goletz, et al.
Radiology|December 2, 1999
Necrotic tumor versus brain abscess: importance of amino acids detected at 1H MR spectroscopy--initial resultsS Grand, G Passaro, A Ziegler, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 2, 1999
Use of carrier cells to deliver a replication-selective herpes simplex virus-1 mutant for the intraperitoneal therapy of epithelial ovarian cancerG Coukos, A Makrigiannakis, E H Kang, et al.
Journal of the National Cancer Institute|June 13, 1998
Molecular evidence for multifocal papillary serous carcinoma of the peritoneum in patients with germline BRCA1 mutationsJ O Schorge, M G Muto, W R Welch, et al.
RNA (New York, N.Y.)|October 13, 2018
Apobec1 complementation factor (A1CF) and RBM47 interact in tissue-specific regulation of C to U RNA editing in mouse intestine and liverValerie Blanc, Yan Xie, Susan Kennedy, et al.
Cellular and Molecular Gastroenterology and Hepatology|August 11, 2024
A Novel CRISPR/Cas9-mediated Mouse Model of Colon CarcinogenesisHajime Kashima, Anthony Fischer, Daniel A Veronese-Paniagua, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 31, 2024
Quantum computation of stopping power for inertial fusion target designNicholas C Rubin, Dominic W Berry, Alina Kononov, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 21, 2007
Tumor residual after surgical cytoreduction in prediction of clinical outcome in stage IV epithelial ovarian cancer: a Gynecologic Oncology Group StudyWilliam E Winter, G Larry Maxwell, Chunqiao Tian, et al.
Gynecologic Oncology|January 11, 1991
Chemotherapy-induced neutropenia and fever in patients receiving cisplatin-based chemotherapy for ovarian malignancyJ P Curtin, W J Hoskins, S C Rubin, et al.
Gynecologic Oncology|September 28, 2011
A high response rate to liposomal doxorubicin is seen among women with BRCA mutations treated for recurrent epithelial ovarian cancerSarah F Adams, Evelyn B Marsh, Wafic Elmasri, et al.
Pageof 72